Matches in SemOpenAlex for { <https://semopenalex.org/work/W2103503232> ?p ?o ?g. }
- W2103503232 endingPage "1552" @default.
- W2103503232 startingPage "1546" @default.
- W2103503232 abstract "Introduction: Sequential high dose (SHiDo) chemotherapy with stem cell support has been shown to prolong the event-free survival in patients with diffuse large B-cell lymphoma.Methods: To confirm this result in a multicenter trial, we randomized patients with aggressive NHL, to receive either eight cycles of CHOP or SHiDo. The primary endpoint was overall survival.Results: 129 evaluable patients were randomized to receive either CHOP or SHiDo: median age, 48 years; 62% male; stage III+IV: 73%; age adjusted International Prognostic Index 1/2/3: 21%/52%/27%. Toxicity grades 3+4 were more pronounced in the SHiDo-arm with 13% versus 3% of patients with fever; 34% versus 13% with infections; 13% versus 2% with esophagitis/dysphagia/gastric ulcer. The remission rates were similar in SHiDo and CHOP arms with 34%/37% complete remissions and 31%/31% partial remissions, respectively. After a median observation time of 48 months, there was no difference in overall survival at 3 years, with 46% for SHiDo and 53% for CHOP (P = 0.48).Conclusion: In this multicenter trial, early intensification with SHiDo did not confer any survival benefit in previously untreated patients with aggressive NHL and was associated with a higher incidence of grades 3/4 toxicity." @default.
- W2103503232 created "2016-06-24" @default.
- W2103503232 creator A5001536238 @default.
- W2103503232 creator A5003887338 @default.
- W2103503232 creator A5005708709 @default.
- W2103503232 creator A5011398209 @default.
- W2103503232 creator A5021127401 @default.
- W2103503232 creator A5024907619 @default.
- W2103503232 creator A5030996590 @default.
- W2103503232 creator A5038634249 @default.
- W2103503232 creator A5046493674 @default.
- W2103503232 creator A5047468243 @default.
- W2103503232 creator A5049104928 @default.
- W2103503232 creator A5055437710 @default.
- W2103503232 creator A5073342980 @default.
- W2103503232 creator A5081516283 @default.
- W2103503232 creator A5087532681 @default.
- W2103503232 date "2006-10-01" @default.
- W2103503232 modified "2023-10-09" @default.
- W2103503232 title "Sequential high dose chemotherapy as initial treatment for aggressive sub-types of Non-Hodgkin Lymphoma: results of the international randomized phase III trial (MISTRAL)" @default.
- W2103503232 cites W1541496572 @default.
- W2103503232 cites W1544519462 @default.
- W2103503232 cites W1819949687 @default.
- W2103503232 cites W1895128059 @default.
- W2103503232 cites W1901299664 @default.
- W2103503232 cites W1997353354 @default.
- W2103503232 cites W2058015212 @default.
- W2103503232 cites W2059707463 @default.
- W2103503232 cites W2074889229 @default.
- W2103503232 cites W2096470130 @default.
- W2103503232 cites W2097575811 @default.
- W2103503232 cites W2131508403 @default.
- W2103503232 cites W2149617816 @default.
- W2103503232 cites W2161026651 @default.
- W2103503232 cites W2167237412 @default.
- W2103503232 cites W2167571754 @default.
- W2103503232 cites W2225927535 @default.
- W2103503232 cites W2263814165 @default.
- W2103503232 cites W2318772898 @default.
- W2103503232 cites W2339293928 @default.
- W2103503232 cites W4242589154 @default.
- W2103503232 doi "https://doi.org/10.1093/annonc/mdl153" @default.
- W2103503232 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16888080" @default.
- W2103503232 hasPublicationYear "2006" @default.
- W2103503232 type Work @default.
- W2103503232 sameAs 2103503232 @default.
- W2103503232 citedByCount "38" @default.
- W2103503232 countsByYear W21035032322012 @default.
- W2103503232 countsByYear W21035032322013 @default.
- W2103503232 countsByYear W21035032322014 @default.
- W2103503232 countsByYear W21035032322015 @default.
- W2103503232 countsByYear W21035032322020 @default.
- W2103503232 crossrefType "journal-article" @default.
- W2103503232 hasAuthorship W2103503232A5001536238 @default.
- W2103503232 hasAuthorship W2103503232A5003887338 @default.
- W2103503232 hasAuthorship W2103503232A5005708709 @default.
- W2103503232 hasAuthorship W2103503232A5011398209 @default.
- W2103503232 hasAuthorship W2103503232A5021127401 @default.
- W2103503232 hasAuthorship W2103503232A5024907619 @default.
- W2103503232 hasAuthorship W2103503232A5030996590 @default.
- W2103503232 hasAuthorship W2103503232A5038634249 @default.
- W2103503232 hasAuthorship W2103503232A5046493674 @default.
- W2103503232 hasAuthorship W2103503232A5047468243 @default.
- W2103503232 hasAuthorship W2103503232A5049104928 @default.
- W2103503232 hasAuthorship W2103503232A5055437710 @default.
- W2103503232 hasAuthorship W2103503232A5073342980 @default.
- W2103503232 hasAuthorship W2103503232A5081516283 @default.
- W2103503232 hasAuthorship W2103503232A5087532681 @default.
- W2103503232 hasBestOaLocation W21035032321 @default.
- W2103503232 hasConcept C126322002 @default.
- W2103503232 hasConcept C141071460 @default.
- W2103503232 hasConcept C168563851 @default.
- W2103503232 hasConcept C203092338 @default.
- W2103503232 hasConcept C2775965419 @default.
- W2103503232 hasConcept C2776694085 @default.
- W2103503232 hasConcept C2779134260 @default.
- W2103503232 hasConcept C2779338263 @default.
- W2103503232 hasConcept C2779725641 @default.
- W2103503232 hasConcept C2779920096 @default.
- W2103503232 hasConcept C29730261 @default.
- W2103503232 hasConcept C2992435398 @default.
- W2103503232 hasConcept C43270747 @default.
- W2103503232 hasConcept C71924100 @default.
- W2103503232 hasConcept C90924648 @default.
- W2103503232 hasConceptScore W2103503232C126322002 @default.
- W2103503232 hasConceptScore W2103503232C141071460 @default.
- W2103503232 hasConceptScore W2103503232C168563851 @default.
- W2103503232 hasConceptScore W2103503232C203092338 @default.
- W2103503232 hasConceptScore W2103503232C2775965419 @default.
- W2103503232 hasConceptScore W2103503232C2776694085 @default.
- W2103503232 hasConceptScore W2103503232C2779134260 @default.
- W2103503232 hasConceptScore W2103503232C2779338263 @default.
- W2103503232 hasConceptScore W2103503232C2779725641 @default.
- W2103503232 hasConceptScore W2103503232C2779920096 @default.
- W2103503232 hasConceptScore W2103503232C29730261 @default.
- W2103503232 hasConceptScore W2103503232C2992435398 @default.
- W2103503232 hasConceptScore W2103503232C43270747 @default.
- W2103503232 hasConceptScore W2103503232C71924100 @default.